Research technologies - Novo Nordisk
WEBLearn how Novo Nordisk uses protein and peptide technology, stem cell technology, RNAi and genome editing to discover and develop new medicines for diabetes and other chronic diseases. Explore their collaborations, platforms and strategies for …
R&D pipeline - Novo Nordisk
WEBNovo Nordisk is a global healthcare company that develops innovative treatments for diabetes, obesity, cardiovascular disease and more. Explore their R&D pipeline by therapy area and study phase, and learn about their scientific approach and research technologies.
Research & technology centres - Novo Nordisk
WEBNovo Nordisk has 12 research and discovery units across China, Denmark, India, the UK and the US. Learn about the scientific and technological expertise, innovation and partnerships of each centre and its role in developing new medicines for chronic diseases.
Novo Nordisk partners with Microsoft for AI-driven drug discovery
WEBSep 13, 2022 · Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI).
Revolutionizing Drug Development: Novo Nordisk’s AI-Powered …
WEBApr 5, 2024 · A long-established global pharmaceutical leader that celebrated its 100 year anniversary in 2023, the company is now pioneering the course in integrating AI in its research and development endeavors in order to leverage groundbreaking technology to …
Novo Nordisk bets $600M biobucks on NanoVation's ability to …
WEB4 days ago · Novo Nordisk is continuing its push into genetic medicines, agreeing to pay NanoVation Therapeutics up to $600 million to collaborate on up to seven programs built on technology for targeting ...
News details - Novo Nordisk
WEBOct 2, 2023 · Novo Nordisk is a leading global healthcare company that has been making innovative medicines to help people with diabetes lead longer, healthier lives for 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity and rare blood and ...
Novo Nordisk - Wikipedia
WEBNovo Nordisk is a global leader in diabetes care and other health products, with headquarters in Bagsværd, Denmark. It was formed in 1989 by the merger of two Danish companies, and has a history of innovation, sustainability and growth.
The Novo Nordisk Foundation, the owner of Ozempic maker, is ... - CNN
WEBMar 19, 2024 · The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of...
Novo Nordisk - Tech Life
WEBJoin 5000 tech enthusiasts across 80 countries at Novo Nordisk in helping people living with serious chronic diseases. Powered by cutting edge technologies, let’s drive change together.
Skip to content